trending Market Intelligence /marketintelligence/en/news-insights/trending/KQCkOpOHXiIo3JFn2OH3tg2 content esgSubNav
In This List

Nephros receives US FDA marketing clearance for HydraGuard system

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise

Blog

Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises


Nephros receives US FDA marketing clearance for HydraGuard system

Nephros Inc. received 510(k) clearance from the U.S. FDA for its HydraGuard 10" UltraFilter, a system for use with a hemodialysis machine for the treatment of patients with end stage renal disease.

The product is designed to provide hospitals and medical facilities with a long-term solution to protect patients from bacteria that may be present in the potable water systems.